News
The cost of the weight-loss drug is set to soar by 170pc, but there are steps you can take to mitigate the rise ...
GoodRx and Novo Nordisk are partnering to lower costs for Ozempic and Wegovy. Patients can use GoodRx to access ...
51m
Investor's Business Daily on MSNIBD Stock Of The Day Boston Scientific Breaks Out — Here's Why
Boston Scientific is Wednesday's IBD Stock Of The Day. Shares are breaking a short-term trendline at their 50-day moving ...
1h
OK Magazine on MSN'Deranged' Donald Trump Shocks Critics by Claiming He Invented the Word 'Equalize'
Donald Trump continues to prove how his vocabulary is one of a kind. In May, the president addressed the public during a ...
The state must cut $100 million from State Health Benefits Program, which has faced double-digit premium hikes for the last ...
Regulations aiming to lower the cost of vital medicines will instead end up restricting access and disincentivizing R&D.
Novo Nordisk is a sector leader in the fast-growing GLP-1 market, boasting strong fundamentals. Click here to read why I rate ...
I am responding to the Aug. 10 Daily Camera editorial, “We need leaders willing to reject the politics of division.” ...
With three new antibiotics set to shake up the stagnant treatment landscape for uncomplicated urinary tract infections (uUTIs ...
Vertex Pharmaceuticals (NASDAQ: VRTX) has been a top pharma stock in recent years. It has been generating strong revenue ...
With many PBMs under scrutiny, smaller startups that bill themselves as transparent are seeing interest from employers.
Pfizer's forward dividend yield currently stands at 6.86%. This yield is so attractive that I wondered if it's the highest of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results